Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1982 Apr 1;203(1):303–311. doi: 10.1042/bj2030303

Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets.

H Sandberg, L O Andersson, S Höglund
PMCID: PMC1158224  PMID: 7103943

Abstract

Lipid-protein particles with platelet factor 3 measured by the Stypven clotting-time test [Hardisty & Hutton (1966) Br. J. Haematol. 12, 764-776] have been isolated from platelet-release supernatant. Starting material was washed platelets, which were released by treatment with collagen. Purification of the particles from other components in the release material was accomplished by gel filtration on Sepharose CL-4B followed by affinity chromatography on poly-L-lysine-Sepharose CL-4B gel. Chemical characterization showed that the particles were composed of 40% protein, 42% phospholipids, 13% cholesterol and 5% triacylglycerols. The phospholipid composition was 38% phosphatidylcholine, 25% phosphatidylethanolamine, 9% phosphatidylserine, 2% phosphatidic acid and 26% sphingomyelin. No carbohydrate was detected. Electron-microscopic studies revealed the presence of membranous particles with diameters between 70 and 170 nm.

Full text

PDF
303

Images in this article

308-1PLATE 1
on p.308-1
308Fig. 3.
on p.308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axén R., Porath J., Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature. 1967 Jun 24;214(5095):1302–1304. doi: 10.1038/2141302a0. [DOI] [PubMed] [Google Scholar]
  2. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  3. Barton P. G., Hanahan D. J. Some lipid-protein interactions involved in prothrombin activation. Biochim Biophys Acta. 1969 Oct 28;187(3):319–327. doi: 10.1016/0005-2760(69)90005-8. [DOI] [PubMed] [Google Scholar]
  4. Barton P. G., Jackson C. M., Hanahan D. J. Relationship between factor V and activated factor X in the generation of prothrombinase. Nature. 1967 May 27;214(5091):923–924. doi: 10.1038/214923a0. [DOI] [PubMed] [Google Scholar]
  5. Blakesley R. W., Boezi J. A. A new staining technique for proteins in polyacrylamide gels using coomassie brilliant blue G250. Anal Biochem. 1977 Oct;82(2):580–582. doi: 10.1016/0003-2697(77)90197-x. [DOI] [PubMed] [Google Scholar]
  6. Esnouf M. P., Jobin F. Lipids in prothrombin conversion. Thromb Diath Haemorrh Suppl. 1965;17:103–110. [PubMed] [Google Scholar]
  7. Esnouf M. P., Macfarlane R. G. Enzymology and the blood clotting mechanism. Adv Enzymol Relat Areas Mol Biol. 1968;30:255–315. doi: 10.1002/9780470122754.ch6. [DOI] [PubMed] [Google Scholar]
  8. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  9. Fewster M. E., Burns B. J., Mead J. F. Quantitative densitometric thin-layer chromatography of lipids using copper acetate reagent. J Chromatogr. 1969 Aug 5;43(1):120–126. doi: 10.1016/s0021-9673(00)99173-8. [DOI] [PubMed] [Google Scholar]
  10. Gahmberg C. G. External labeling of human erythrocyte glycoproteins. Studies with galactose oxidase and fluorography. J Biol Chem. 1976 Jan 25;251(2):510–515. [PubMed] [Google Scholar]
  11. Hardisty R. M., Hutton R. A. Platelet aggregation and the availability of platelet factor 3. Br J Haematol. 1966 Nov;12(6):764–776. doi: 10.1111/j.1365-2141.1966.tb00164.x. [DOI] [PubMed] [Google Scholar]
  12. Heinz Joist J., Dolezel G., Lloyd J. V., Kinlough-Rathbone R. L., Mustard J. F. Platelet factor-3 availability and the platelet release reaction. J Lab Clin Med. 1974 Oct;84(4):474–482. [PubMed] [Google Scholar]
  13. Hemker H. C., Esnouf M. P., Hemker P. W., Swart A. C., Macfarlane R. G. Formation of prothrombin converting activity. Nature. 1967 Jul 15;215(5098):248–251. doi: 10.1038/215248a0. [DOI] [PubMed] [Google Scholar]
  14. Hemker H. C., Kahn M. J., Devilee P. P. The adsorption of coagulation factors onto phospholipids. Its role in the reaction mechanism of blood coagulation. Thromb Diath Haemorrh. 1970 Oct 31;24(1):214–223. [PubMed] [Google Scholar]
  15. Hemker H. C., Kahn M. J. Reaction sequence of blood coagulation. Nature. 1967 Sep 9;215(5106):1201–1202. doi: 10.1038/2151201a0. [DOI] [PubMed] [Google Scholar]
  16. Holbrook I. B., Leaver A. G. A procedure to increase the sensitivity of staining by Coomassie brilliant blue G250-perchloric acid solution. Anal Biochem. 1976 Oct;75(2):634–636. doi: 10.1016/0003-2697(76)90118-4. [DOI] [PubMed] [Google Scholar]
  17. Horowitz H. I., Papayoanou M. F. Release of nonsedimentable platelet factor 3 during coagulation. J Lab Clin Med. 1967 Jun;69(6):1003–1012. [PubMed] [Google Scholar]
  18. Hougie C., Denson K. W., Biggs R. A study of the reaction product of factor 8 and factor IX by gel filtration. Thromb Diath Haemorrh. 1967 Aug 15;18(1-2):211–222. [PubMed] [Google Scholar]
  19. Kane W. H., Lindhout M. J., Jackson C. M., Majerus P. W. Factor Va-dependent binding of factor Xa to human platelets. J Biol Chem. 1980 Feb 10;255(3):1170–1174. [PubMed] [Google Scholar]
  20. LUNDBLAD R. L., DAVIE E. W. THE ACTIVATION OF ANTIHEMOPHILIC FACTOR (FACTOR 8) BY ACTIVATED CHRISTMAS FACTOR (ACTIVATED FACTOR9 9). Biochemistry. 1964 Nov;3:1720–1725. doi: 10.1021/bi00899a022. [DOI] [PubMed] [Google Scholar]
  21. MARCUS A. J., ULLMAN H. L., SAFIER L. B., BALLARD H. S. Platelet phosphatides. Their fatty acid and aldehyde composition and activity in different clotting systems. J Clin Invest. 1962 Dec;41:2198–2212. doi: 10.1172/JCI104679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. MILSTONE J. H. THROMBOKINASE AS PRIME ACTIVATOR OF PROTHROMBIN: HISTORICAL PERSPECTIVES AND PRESENT STATUS. Fed Proc. 1964 Jul-Aug;23:742–748. [PubMed] [Google Scholar]
  23. Marcus A. J. Platelet function (first of three parts). N Engl J Med. 1969 May 29;280(22):1213–1220. doi: 10.1056/NEJM196905292802206. [DOI] [PubMed] [Google Scholar]
  24. Miletich J. P., Jackson C. M., Majerus P. W. Interaction of coagulation factor Xa with human platelets. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4033–4036. doi: 10.1073/pnas.74.9.4033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Miletich J. P., Jackson C. M., Majerus P. W. Properties of the factor Xa binding site on human platelets. J Biol Chem. 1978 Oct 10;253(19):6908–6916. [PubMed] [Google Scholar]
  26. Miletich J. P., Kane W. H., Hofmann S. L., Stanford N., Majerus P. W. Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood. 1979 Nov;54(5):1015–1022. [PubMed] [Google Scholar]
  27. Miletich J. P., Majerus D. W., Majerus P. W. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets. J Clin Invest. 1978 Oct;62(4):824–831. doi: 10.1172/JCI109194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Norén I. Specific assay of prothrombin. A method using a freeze-dried reagent of intrinsic coagulation factors. Scand J Clin Lab Invest. 1970 Jan;25(1):47–58. doi: 10.3109/00365517009046189. [DOI] [PubMed] [Google Scholar]
  29. PAPAHADJOPOULOS D., HANAHAN D. J. OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION. Biochim Biophys Acta. 1964 Aug 19;90:436–439. doi: 10.1016/0304-4165(64)90220-x. [DOI] [PubMed] [Google Scholar]
  30. Reisner A. H., Nemes P., Bucholtz C. The use of Coomassie Brilliant Blue G250 perchloric acid solution for staining in electrophoresis and isoelectric focusing on polyacrylamide gels. Anal Biochem. 1975 Apr;64(2):509–516. doi: 10.1016/0003-2697(75)90461-3. [DOI] [PubMed] [Google Scholar]
  31. SABATINI D. D., BENSCH K., BARRNETT R. J. Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation. J Cell Biol. 1963 Apr;17:19–58. doi: 10.1083/jcb.17.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sandberg H., Andersson L. O. Studies of the thromboplastic effect of human plasma lipoproteins. Thromb Haemost. 1976 Feb 29;35(1):178–185. [PubMed] [Google Scholar]
  33. Schiffman S., Rapaport S. I., Chong M. M. The mandatory role of lipid in the interaction of factors 8 and 9. Proc Soc Exp Biol Med. 1966 Dec;123(3):736–740. doi: 10.3181/00379727-123-31590. [DOI] [PubMed] [Google Scholar]
  34. Tracy P. B., Peterson J. M., Nesheim M. E., McDuffie F. C., Mann K. G. Interaction of coagulation factor V and factor Va with platelets. J Biol Chem. 1979 Oct 25;254(20):10354–10361. [PubMed] [Google Scholar]
  35. Walsh P. N., Biggs R. The role of platelets in intrinsic factor-Xa formation. Br J Haematol. 1972 Jun;22(6):743–760. doi: 10.1111/j.1365-2141.1972.tb05719.x. [DOI] [PubMed] [Google Scholar]
  36. Webber A. J., Johnson S. A. Platelet participation in blood coagulation aspects of hemostasis. Am J Pathol. 1970 Jul;60(1):19–42. [PMC free article] [PubMed] [Google Scholar]
  37. White J. G., Krivit W. The ultrastructural localization and release of platelet lipids. Blood. 1966 Feb;27(2):167–186. [PubMed] [Google Scholar]
  38. Williams R. C., Fisher H. W. Electron microscopy of tobacco mosaic virus under conditions of minimal beam exposure. J Mol Biol. 1970 Aug 28;52(1):121–123. doi: 10.1016/0022-2836(70)90181-6. [DOI] [PubMed] [Google Scholar]
  39. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967 May;13(3):269–288. doi: 10.1111/j.1365-2141.1967.tb08741.x. [DOI] [PubMed] [Google Scholar]
  40. Wyckoff M., Rodbard D., Chrambach A. Polyacrylamide gel electrophoresis in sodium dodecyl sulfate-containing buffers using multiphasic buffer systems: properties of the stack, valid Rf- measurement, and optimized procedure. Anal Biochem. 1977 Apr;78(2):459–482. doi: 10.1016/0003-2697(77)90107-5. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES